251 related articles for article (PubMed ID: 26595082)
1. Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.
Yakushijin K; Atsuta Y; Doki N; Yokota A; Kanamori H; Miyamoto T; Ohwada C; Miyamura K; Nawa Y; Kurokawa M; Mizuno I; Mori T; Onizuka M; Taguchi J; Ichinohe T; Yabe H; Morishima Y; Kato K; Suzuki R; Fukuda T
Bone Marrow Transplant; 2016 Mar; 51(3):403-9. PubMed ID: 26595082
[TBL] [Abstract][Full Text] [Related]
2. Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.
Faraci M; Bertaina A; Luksch R; Calore E; Lanino E; Saglio F; Prete A; Menconi M; De Simone G; Tintori V; Cesaro S; Santarone S; Orofino MG; Locatelli F; Zecca M
Biol Blood Marrow Transplant; 2019 Feb; 25(2):313-320. PubMed ID: 30266674
[TBL] [Abstract][Full Text] [Related]
3. Early Clinical Predictors of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Myeloablative Stem Cell Transplantation.
Roeker LE; Kim HT; Glotzbecker B; Nageshwar P; Nikiforow S; Koreth J; Armand P; Cutler C; Alyea EP; Antin JH; Richardson PG; Soiffer RJ; Ho VT
Biol Blood Marrow Transplant; 2019 Jan; 25(1):137-144. PubMed ID: 30081073
[TBL] [Abstract][Full Text] [Related]
4. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors and outcomes of sinusoidal obstruction syndrome after haploidentical allogeneic stem cell transplantation.
Cai X; Wu J; Gui RY; Huang QS; Liu X; Qin YZ; Wang JZ; Zeng QZ; Jiang Q; Jiang H; Lu J; Wang JB; Gao L; Zhang X; Zhang HY; Feng J; Zhao XY; Chang YJ; Liu YR; Xu LP; Liu KY; Huang XJ; Zhang XH
Ann Hematol; 2019 Jul; 98(7):1733-1742. PubMed ID: 31053879
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of pediatric patients with anicteric and late-onset sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.
Inagaki J; Noguchi M; Fukano R
Pediatr Blood Cancer; 2020 Aug; 67(8):e28412. PubMed ID: 32495502
[TBL] [Abstract][Full Text] [Related]
7. Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia.
Kim H; Lee KH; Sohn SK; Jung CW; Joo YD; Kim SH; Kim BS; Choi JH; Kwak JY; Kim MK; Bae SH; Shin HJ; Won JH; Oh S; Lee WS; Park JH; Yoon SS
Leuk Res; 2013 Oct; 37(10):1241-7. PubMed ID: 23871157
[TBL] [Abstract][Full Text] [Related]
8. Heparanase polymorphisms: influence on incidence of hepatic sinusoidal obstruction syndrome in children undergoing allogeneic hematopoietic stem cell transplantation.
Seifert C; Wittig S; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 May; 141(5):877-85. PubMed ID: 25335953
[TBL] [Abstract][Full Text] [Related]
9. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
10. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Kernan NA; Grupp S; Smith AR; Arai S; Triplett B; Antin JH; Lehmann L; Shore T; Ho VT; Bunin N; Iacobelli M; Liang W; Hume R; Tappe W; Soiffer R; Richardson P
Br J Haematol; 2018 Jun; 181(6):816-827. PubMed ID: 29767845
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH; Giralt SA
Biol Blood Marrow Transplant; 2016 Mar; 22(3):400-9. PubMed ID: 26431626
[TBL] [Abstract][Full Text] [Related]
12. Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.
Battipaglia G; Labopin M; Candoni A; Fanin R; El Cheikh J; Blaise D; Michallet M; Ruggeri A; Contentin N; Ribera JM; Stadler M; Sierra J; von dem Borne PA; Bloor A; Socié G; Nagler A; Mohty M
Bone Marrow Transplant; 2017 Apr; 52(4):592-599. PubMed ID: 28092357
[TBL] [Abstract][Full Text] [Related]
13. Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation.
Weischendorff S; Kielsen K; Sengeløv H; Jordan K; Nielsen CH; Pedersen AE; Ryder LP; Juul A; Müller KG
Bone Marrow Transplant; 2017 Jun; 52(6):863-869. PubMed ID: 28436969
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation.
Yakushijin K; Ikezoe T; Ohwada C; Kudo K; Okamura H; Goto H; Yabe H; Yasumoto A; Kuwabara H; Fujii S; Kagawa K; Ogata M; Onishi Y; Kohno A; Watamoto K; Uoshima N; Nakamura D; Ota S; Ueda Y; Oyake T; Koike K; Mizuno I; Iida H; Katayama Y; Ago H; Kato K; Okamura A; Kikuta A; Fukuda T
Bone Marrow Transplant; 2019 May; 54(5):674-680. PubMed ID: 30127466
[TBL] [Abstract][Full Text] [Related]
15. Analysis of laboratory parameters before the occurrence of hepatic sinusoidal obstruction syndrome in children, adolescents, and young adults after hematopoietic stem cell transplantation.
Johann L; Gruhn B
J Cancer Res Clin Oncol; 2024 Jan; 150(1):9. PubMed ID: 38206490
[TBL] [Abstract][Full Text] [Related]
16. Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
El-Serafi I; Remberger M; Ringdèn O; Törlén J; Sundin M; Björklund A; Winiarski J; Mattsson J
Clin Transl Sci; 2020 Mar; 13(2):293-300. PubMed ID: 31675173
[TBL] [Abstract][Full Text] [Related]
17. Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation.
Park M; Park HJ; Eom HS; Kwon YJ; Park JA; Lim YJ; Yoon JH; Kong SY; Ghim TT; Lee HW; Yun T; Park BK
Ann Transplant; 2013 Jan; 18():36-42. PubMed ID: 23792499
[TBL] [Abstract][Full Text] [Related]
18. Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
Lai X; Liu L; Zhang Z; Shi L; Yang G; Wu M; Huang R; Liu R; Lai Y; Li Q
Bone Marrow Transplant; 2021 Jul; 56(7):1635-1641. PubMed ID: 33608657
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and risk factors of hepatic sinusoidal obstruction syndrome in children after hematopoietic stem cell transplantation: A single-center experience.
Kartal İ; Albayrak C; Dağdemir A; Dinçer OS; Şimşek HK; Özgen Ü; Albayrak D
Transfus Apher Sci; 2024 Jun; 63(3):103909. PubMed ID: 38467529
[TBL] [Abstract][Full Text] [Related]
20. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.
Carreras E; Díaz-Beyá M; Rosiñol L; Martínez C; Fernández-Avilés F; Rovira M
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1713-20. PubMed ID: 21708110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]